← FDA Drug Approvals (Drugs@FDA)
NASONEX 24HR ALLERGY
NDA · New Drug Application · Sponsor: PERRIGO PHARMA INTL · Approved 2022-03-17
Drug application
- FDA Application #
NDA215712- Application type
- New Drug Application
- Brand name
- NASONEX 24HR ALLERGY
- Generic name
- MOMETASONE FUROATE
- Active ingredients
- MOMETASONE FUROATE
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Marketing status
- Over-the-counter
- Sponsor
- PERRIGO PHARMA INTL
- Manufacturer
- Rugby Laboratories
- First approval
- 2022-03-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown